Storage Condition
Store at refrigerator (2-8°C) for long term storage
Application Notes
Useful research chemical for a range of applications
Purity by HPLC
Not less than 90%
Hazard Compound
Refer MSDS for complete information
endo-Gly9a-Vasopressin is a drug product that is used as an analytical standard for HPLC, as well as in research and development of drugs.
Refund Policy
We are committed to offering products of the highest quality in order to meet the needs of our customers, and have elaborate systems in
place to ensure that material specifications, their certification and all handling and storage conditions are communicated at the time of
material handover.
We have invested in the highest quality packaging materials and use international logistics partners to service our customers. While all
possible precautions have been taken to deliver the required product(s), there may be some rare situations when our product does not
meet your requirements. Should that arise, please contact us with your concerns and we will endeavour to address them on a priority
basis. If there is no other option, we will either replace your product(s) or issue a refund or account credit, whichever you prefer.
If there is an issue with one or more of our products, our policy is that it must be reported to us within 45 days of your receiving shipment.
While we will always address product issues after the 45 day return window has passed, we cannot issue a refund or account credit. As
always, we appreciate your support.
endo-Gly9a-Vasopressin usage and description
Endo-Gly9a-Vasopressin (EGV) is a neuropeptide hormone that is involved in regulating several physiological functions in the body. It is a modified form of vasopressin, a hormone that is important for regulating water balance in the body. EGV is derived from the precursor protein preprovasopressin, which is synthesized in the hypothalamus and then transported to the posterior pituitary gland for release into circulation.
EGV has been shown to have a variety of effects in the body, including vasoconstriction, antidiuretic activity, and stimulation of the release of corticotrophin hormone. It is also involved in regulating the secretion of other hormones such as oxytocin and prolactin.
The chemical structure of EGV consists of nine amino acids, with a glycine residue at the ninth position. This modification is believed to increase the stability of the peptide and enhance its biological activity. EGV is also known to have a longer half-life than vasopressin, which means it can remain active in the body for a longer period of time.
EGV is used in research studies to investigate its potential therapeutic applications, particularly in the treatment of certain disorders such as diabetes insipidus and hypotension. Its unique chemical structure and biological activity make it an important tool for understanding the complex interactions between neuropeptides and the body's physiological processes.
